Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

BioSyent acquires Oral Science for growth

PRIVATEAug 24, 2026•about 4 hours ago

Acquiring Company

BioSyent

Acquired Company

Oral Science

MississaugaCanada

Description

BioSyent Inc. has successfully acquired Oral Science, marking a significant expansion into the oral health sector. This acquisition aims to reduce dependence on the legacy pharmaceutical portfolio and enhance overall business diversification. The newly acquired segment has already begun contributing positively to company-wide sales and earnings. Management emphasizes the strategic fit of this acquisition within its broader growth strategy.

Company Information

Company

BioSyent

Location

Mississauga, Ontario, Canada

About

BioSyent Inc. is a Canadian pharmaceutical and health products company. It specializes in the development and marketing of innovative healthcare products. BioSyent is listed on the TSX Venture Exchange and focuses on expanding its market reach in both Canadian and international markets.

Don't miss BioSyent's next move

Get an email the moment BioSyent makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for BioSyent's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Oral Science?

Oral Science was acquired by BioSyent, based in Mississauga. The deal was reported on August 24, 2026. BioSyent Inc. is a Canadian pharmaceutical and health products company. It specializes in the development and marketing of innovative healthcare products. BioSyent is privately held.

When did BioSyent acquire Oral Science?

BioSyent's acquisition of Oral Science was reported on August 24, 2026. BioSyent Inc. has successfully acquired Oral Science, marking a significant expansion into the oral health sector. This acquisition aims to reduce dependence on the legacy pharmaceutical portfolio and enhance overall business diversification. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Oral Science do?

Oral Science Inc. is a Canadian company that specializes in the development and distribution of dental hygiene and oral health products. The company focuses on innovative solutions to improve oral health. It is privately held, and is based in Canada.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.